CytoMed Therapeutics Limited (GDTC)
Nasdaq: GDTC · Pharmaceutical Preparations · 1 Commonwealth Lane, SG · filing with the SEC since 2021
Who owns CytoMed Therapeutics Limited
As filed with the SECHolders of 5% or more
3
Choo Chee Kong holds 25.2% of Ordinary Shares, as its SCHEDULE 13D/A filed Oct 16, 2026 says.
Directors and officers
6
report now, of 10 people on the record since 2023. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Choo Chee Kong
SCHEDULE 13D/A · filed Oct 16, 2026 · Ordinary Shares · 24.9% in Oct 13, 2026
mDR LTD
SCHEDULE 13G/A · filed Oct 23, 2026 · Ordinary Shares, no par value per share · 11.3% in Mar 24, 2025
28 Consultants Ltd
SCHEDULE 13G · filed Mar 4, 2025 · Ordinary Shares, no par value
What GDTC reports owning in othersstakes of 5% or more, and other ties
CytoMed Therapeutics Limited reports no stake in another company in the record.
Insider tradesForm 4
0sales
5purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$700,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 12 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Choo Chee Kong | director | 0 | $0 | 0 | 5 | $700,000 |